Related Experiment Video
Updated: Jun 7, 2025

Ferric Chloride-induced Murine Thrombosis Models
Published on: September 5, 2016
The Role of Platelets in Atherosclerosis: A Historical Review
Stefania Momi1, Paolo Gresele1
1Department of Medicine and Surgery, University of Perugia, Perugia, Italy.
Insights
Platelets play a key role in atherosclerosis development by interacting with the arterial wall and leukocytes. Targeting platelet secretion and adhesion may offer new strategies to prevent cardiovascular disease progression.
Area of Science:
- Cardiovascular Science
- Inflammation Biology
- Hematology
Background:
- Atherosclerosis is a major cause of global cardiovascular mortality.
- Platelets are primarily known for thrombosis but also contribute to atherosclerosis development.
- Platelet interactions with the arterial wall and leukocytes are critical in atherogenesis.
Purpose of the Study:
- To elucidate the multifaceted role of platelets in all stages of atherosclerosis.
- To explore how platelets initiate and promote inflammatory processes in artery walls.
- To identify novel therapeutic targets for preventing atherosclerosis progression.
Main Methods:
- Review of existing literature on platelet function in atherosclerosis.
- Analysis of platelet interactions with endothelial cells and leukocytes.
- Examination of molecular mechanisms involving platelet-derived mediators like MMPs and chemokines.
Main Results:
- Platelets contribute to endothelial dysfunction and leukocyte adhesion via MMPs and adhesion molecules (P-selectin, glycoprotein Ibα).
- Platelet-leukocyte interactions generate reactive oxygen species, promoting lipid peroxidation.
- Platelets migrate into the arterial wall, releasing chemokines that modulate the inflammatory microenvironment.
Conclusions:
- Platelets are integral to atherogenesis, from initial endothelial damage to plaque progression.
- Current antiplatelet therapies may not fully address platelet-driven atherogenesis.
- Inhibiting platelet secretion, MMP release, and specific adhesion pathways presents promising therapeutic avenues.
Abstract:
Atherosclerosis is a chronic, multifactorial inflammatory disorder of large and medium-size arteries, which is the leading cause of cardiovascular mortality and morbidity worldwide. Although platelets in cardiovascular disease have mainly been studied for their crucial role in the thrombotic event triggered by atherosclerotic plaque rupture, over the last two decades it has become clear that platelets participate also in the development of atherosclerosis, owing to their ability to interact with the damaged arterial wall and with leukocytes. Platelets participate in all phases of atherogenesis, from the initial functional damage to endothelial cells to plaque unstabilization. Platelets deposit at atherosclerosis predilection sites before the appearance of manifest lesions to the endothelium and contribute to induce endothelial dysfunction, thus supporting leukocyte adhesion to the vessel wall. In particular, platelets release matrix metalloproteinases, which interact with protease-activated receptor 1 on endothelial cells triggering adhesion molecule expression. Moreover, P-selectin and glycoprotein Ibα expressed on the surface of vessel wall-adhering platelets bind PSGL-1 and β2 integrins on leukocytes, favoring their arrest and transendothelial migration. Platelet-leukocyte interactions promote the formation of radical oxygen species which are strongly involved in the lipid peroxidation associated with atherosclerosis. Platelets themselves actively migrate through the endothelium toward the plaque core where they release chemokines that modify the microenvironment by modulating the function of other inflammatory cells, such as macrophages. While current antiplatelet agents seem unable to prevent the contribution of platelets to atherogenesis, the inhibition of platelet secretion, of the release of MMPs, and of some specific pathways of platelet adhesion to the vessel wall may represent promising future strategies for the prevention of atheroprogression.
Related Concept Videos
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Clot Retraction and Fibrinolysis
Inflammation

